查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
帕金森病藥物市場規模、份額和趨勢分析報告：按藥物類別（卡比多巴/左旋多巴、抗膽鹼能藥）、分銷渠道（醫院、零售藥房）、地區、細分市場預測2022-2030
市場調查報告書
商品編碼
1171113

帕金森病藥物市場規模、份額和趨勢分析報告：按藥物類別（卡比多巴/左旋多巴、抗膽鹼能藥）、分銷渠道（醫院、零售藥房）、地區、細分市場預測2022-2030

Parkinson's Disease Treatment Market Size, Share & Trends Analysis Report By Drug Class (Carbidopa-levodopa, Anticholinergics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

帕金森病藥物市場的增長和趨勢

Grand View Research, Inc. 的最新報告預測，到 2030 年，全球帕金森病治療藥物市場規模將達到 119.8 億美元，2022 年至 2030 年的複合年增長率為 12.1%。 這可能是由於增加了對 PD 新療法研發的投資。 2021 年 8 月，帕金森基金會宣布投資 4300 萬美元用於 29 個研究項目的研究資助，旨在開發 PD 的新療法和療法。 此外，2021 年 5 月，帕金森基金會宣布投資 1000 萬美元用於帕金森病 (PD) 的研究、護理和教育項目。 這項投資將有助於提高認識並為患有 PD 的人提供免費基因檢測。

預計此類投資計劃將推動該行業的發展。 在過去的十年中，PD 治療領域出現了重大的研發活動，導致了創新藥物輸送方法的發展。 由於副作用較少，這些最先進的藥物輸送系統優於現有系統。 此外，患者依從性的提高導致這些技術的處方率更高，從而推動了行業擴張。 此外，主要製藥公司正在開展合作和夥伴關係，以開發、製造和商業化產品，以滿足國際市場對疾病治療日益增長的需求。

例如，2021 年 11 月，STADA Arzneimittel 和 Bioglan 建立了合作夥伴關係，以擴大用於治療 PD 患者的藥物 Lecigon（左旋多巴/卡比多巴/恩他卡朋）的產能。 因此，對用於治療 PD 患者的藥物的需求增加預計將推動行業增長。 但由於神經外科醫生數量有限，存在患者等待時間長、醫院難以招募新神經外科醫生等問題。 而一些目前在實踐中的神經科醫生避免接受新的醫療補助患者，這使得想要切換到另一位醫生的患者變得困難。 美國神經病學學會 (AAN) 的一份報告預測，到 2025 年，將出現約 19% 的神經科醫生短缺。

帕金森病治療藥物市場報告要點

按藥物類別劃分，卡比多巴和左旋多巴部分在 2021 年佔銷售額的最大份額，因為 PD 患病率高且治療該疾病的藥物隨時可用 *2021 年，零售藥店分銷渠道部分在全球佔據主導地位行業。

這是因為 PD 藥物在成熟的零售連鎖藥店（包括沃爾格林和沃爾瑪）隨時可用

由於新產品進入市場，預計亞太地區在預測期內增長最快

2020 年 6 月，Ono Pharmaceutical Co., Ltd. 在日本獲得了用於治療 PD 患者的 Ogencys 的生產和銷售批准

內容

第1章調查方法及範圍

  • 市場細分和範圍
    • 細分範圍
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫：
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的內容
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析
      • 方法：產品流方法
  • 調查假設
  • 二級信息列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場展望

第 3 章帕金森病藥物市場變量、趨勢和範圍

  • 母公司市場展望
    • 中樞神經系統藥物市場
  • 描繪滲透率和增長前景
  • 監管和報銷方案
  • 市場驅動因素分析
    • 帕金森病的患病率增加
    • 擁有強大的渠道
    • 新型給藥系統的介紹
  • 市場製約因素分析
    • 治療費用高
    • 神經科醫生和神經外科醫生短缺
  • 主要交易和戰略聯盟
  • 管道分析
  • SWOT 因素分析（政治和法律、經濟、技術）
  • 行業分析 - 搬運工

第 4 章帕金森藥物市場：競爭分析

  • 主要市場進入者的近期趨勢和影響分析
    • 新產品發布
    • 併購
    • 夥伴關係和戰略協作
    • 會議和活動
  • 公司分類
    • 創新者
    • 市場領導者
    • 熱圖分析
  • 供應商情況
    • 主要分銷商和渠道合作夥伴列表
    • 主要客戶
  • 2021 年主要參與者的市場份額分析
  • 上市公司
    • 企業市場分析
    • 競爭儀表板分析
      • 市場差異化因素
  • 私人公司
    • 主要初創公司名單
    • 本地網絡地圖

第 5 章帕金森病藥物市場：細分分析，按藥物類別，2018-2030 年（百萬美元）

  • 帕金森病治療市場：藥物類別的變化分析
  • 卡比多巴-左旋多巴
  • 多巴胺激動劑
  • MAO-B 抑製劑
  • COMT抑製劑
  • 抗膽鹼藥
  • 其他

第 6 章。帕金森病藥物市場：細分分析，按分銷渠道，2018-2030 年（百萬美元）

  • 帕金森病治療市場：分銷渠道波動分析
  • 醫院藥房
  • 零售藥房
  • 在線藥店

第 7 章帕金森病藥物市場：按地區劃分的細分分析，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2021 年和 2030 年區域市場份額分析
  • 區域市場概況
  • 2021-2030 年市場規模、預測、收入和趨勢分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 西班牙
      • 法國
      • 意大利
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 澳大利亞
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 多邊環境協定
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

第 8 章帕金森藥物市場：公司概況

  • 公司簡介
    • Cerevel Therapeutics
      • 公司簡介
      • 財務業績
      • 產品基準
      • 最近的發展
    • 諾華公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 最近的發展
    • 梯瓦製藥工業有限公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 最近的發展
    • 默克公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 最近的發展
    • 葛蘭素史克公司 (GSK)
      • 公司簡介
      • 財務業績
      • 產品基準
      • 最近的發展
    • 艾伯維公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 最近的發展
    • H. Lundbeck A/S
      • 公司簡介
      • 財務業績
      • 產品基準
    • Amneal Pharmaceuticals LLC。
      • 公司簡介
      • 財務基準
      • 產品基準
      • 最近的發展
    • Supernus Pharmaceuticals, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 最近的發展
Product Code: GVR-4-68039-990-7

Parkinson's Disease Treatment Market Growth & Trends:

The global Parkinson's disease treatment market size is expected to reach USD 11.98 billion by 2030, according to a new report by Grand View Research, Inc., growing at a CAGR of 12.1% from 2022 to 2030. This can be attributed to the rising investment in the research and development of novel treatments for PD. In August 2021, the Parkinson's Foundation announced an investment of USD 43 million as a research grant to 29 research projects having the goal of developing novel treatments and therapies for PD. In addition, in May 2021, the Parkinson's Foundation announced an investment of USD 10 million for research, care, and educational programs related to Parkinson's Disease (PD). This investment may aid in providing awareness and genetic testing free of cost to people suffering from PD.

Such investment initiatives are expected to boost industry growth. In the last ten years, there have been significant R&D activities in the PD therapy sector, leading to the development of innovative drug-delivery methods. Due to fewer side effects, these cutting-edge drug delivery systems outperform the existing ones. In addition, the rate of prescription for these techniques has increased due to a rise in patient compliance, which is fueling the expansion of the industry. Moreover, key pharmaceutical companies are undertaking initiatives, such as collaborations and partnerships, for the development, manufacturing & commercialization of products to meet the rising demand for disease treatment in the international market.

For instance, in November 2021, STADA Arzneimittel and Bioglan formed a partnership to expand the production capacity of the medicine Lecigon (levodopa/carbidopa/entacapone) used to treat patients with PD. Thus, increasing demand for medicines that are used to treat patients with PD is anticipated to drive industry growth. However, the limited availability of neurologists leads to issues, such as longer waiting times for patients and difficulty in hiring new neurosurgeons in hospitals. In addition, some of the currently practicing neurologists avoid accepting new Medicaid patients, which creates difficulty for patients who want to switch to another doctor. According to the American Academy of Neurology (AAN) report, around 19% shortage of neurologists is projected by 2025.

Parkinson's Disease Treatment Market Report Highlights:

  • By drug class, the Carbidopa-Levodopa segment held the largest revenue share in 2021 due to the high prevalence of PD and easy drug availability for the disease treatment* The retail pharmacy distribution channel segment dominated the global industry in 2021
  • This is due to the easy availability of PD drugs in well-established retail pharmacy chains including Walgreens and Walmart
  • Asia Pacific is expected to be the fastest-growing region during the forecast period due to the entry of new products into the market
  • In June 2020, Ono Pharmaceutical Co., Ltd. received manufacturing and marketing approval for Ongentys to treat patients with PD in Japan

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Parkinson's Disease Treatment Market Variables, Trends, and Scope

  • 3.1 Parent Market Outlook
    • 3.1.1 Central Nervous System Therapeutics Market
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Regulatory & Reimbursement Scenario
  • 3.4 Market Driver Analysis
    • 3.4.1 Increasing prevalence of Parkinson's disease
    • 3.4.2 Presence of strong pipeline drugs
    • 3.4.3 Introduction of novel drug delivery systems
  • 3.5 Market Restraint Analysis
    • 3.5.1 High treatment cost
    • 3.5.2 Lack of neurologist and neurosurgeons
  • 3.6 Major Deals and Strategic Alliances
  • 3.7 Pipeline Analysis
  • 3.8 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
  • 3.9 Industry Analysis - Porter's

Chapter 4 Parkinson's Disease Treatment Market: Competitive Analysis

  • 4.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 4.1.1 New Product Launches
    • 4.1.2 Mergers and Acquisitions
    • 4.1.3 Partnerships and Strategic Collaboration
    • 4.1.4 Conferences and Campaigns
  • 4.2 Company Categorization
    • 4.2.1 Innovators
    • 4.2.2 Market Leaders
    • 4.2.3 Heat map analysis
  • 4.3 Vendor Landscape
    • 4.3.1 List of key distributors and channel partners
    • 4.3.2 Key customers
  • 4.4 Key Company Market Share Analysis, 2021
  • 4.5 Public Companies
    • 4.5.1 Company market position analysis
    • 4.5.2 Competitive dashboard analysis
      • 4.5.2.1 Market Differentiators
  • 4.6 Private Companies
    • 4.6.1 List of key emerging companies
    • 4.6.2 Regional Network Map

Chapter 5 Parkinson's Disease Treatment Market: Segment Analysis, by Drug Class, 2018 - 2030 (USD Million)

  • 5.1 Parkinson's Disease Treatment Market: Drug Class Movement Analysis
  • 5.2 Carbidopa-Levodopa
    • 5.2.1 Carbidopa-levodopa market, 2018 - 2030 (USD Million)
  • 5.3 Dopamine Agonists
    • 5.3.1 Dopamine agonists market, 2018 - 2030 (USD Million)
  • 5.4 MAO-B Inhibitors
    • 5.4.1 MAO-B inhibitors market, 2018 - 2030 (USD Million)
  • 5.5 COMT inhibitors
    • 5.5.1 COMT inhibitors market, 2018 - 2030 (USD Million)
  • 5.6 Anticholinergics
    • 5.6.1 Anticholinergics market, 2018 - 2030 (USD Million)
  • 5.7 Others
    • 5.7.1 Others market, 2018 - 2030 (USD Million)

Chapter 6 Parkinson's Disease Treatment Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)

  • 6.1 Parkinson's Disease Treatment Market: Distribution Channel Movement Analysis
  • 6.2 Hospital Pharmacy
    • 6.2.1 Hospital pharmacy market, 2018 - 2030 (USD Million)
  • 6.3 Retail Pharmacy
    • 6.3.1 Retail pharmacy market, 2018 - 2030 (USD Million)
  • 6.4 Online Pharmacy
    • 6.4.1 Online pharmacy market, 2018 - 2030 (USD Million)

Chapter 7 Parkinson's Disease Treatment Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2021 & 2030
  • 7.3 Regional Market Snapshot
  • 7.4 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
    • 7.4.1 North America
      • 7.4.1.1 North America Parkinson's disease treatment, 2018-2030 (USD Million)
      • 7.4.1.2 U.S.
      • 7.4.1.2.1 U.S. Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.1.3 Canada
      • 7.4.1.3.1 Canada Parkinson's disease treatment market, 2018 - 2030 (USD Million)
    • 7.4.2 Europe
      • 7.4.2.1 Europe Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.2.2 U.K.
      • 7.4.2.2.1 U.K. Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.2.3 Germany
      • 7.4.2.3.1 Germany Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.2.4 Spain
      • 7.4.2.4.1 Spain Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.2.5 France
      • 7.4.2.5.1 France Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.2.6 Italy
      • 7.4.2.6.1 Italy Parkinson's disease treatment market, 2018 - 2030 (USD Million)
    • 7.4.3 Asia Pacific
      • 7.4.3.1 Asia Pacific Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.3.2 Japan
      • 7.4.3.2.1 Japan Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.3.3 China
      • 7.4.3.3.1 China Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.3.4 India
      • 7.4.3.4.1 India Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.3.5 South Korea
      • 7.4.3.5.1 South Korea Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.3.6 Australia
      • 7.4.3.6.1 Australia Parkinson's disease treatment market, 2018 - 2030 (USD Million)
    • 7.4.4 Latin America
      • 7.4.4.1 Latin America Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.4.2 Brazil
      • 7.4.4.2.1 Brazil Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.4.3 Mexico
      • 7.4.4.3.1 Mexico Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.4.4 Argentina
      • 7.4.4.4.1 Argentina Parkinson's disease treatment market, 2018 - 2030 (USD Million)
    • 7.4.5 MEA
      • 7.4.5.1 MEA Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.5.2 South Africa
      • 7.4.5.2.1 South Africa Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.5.3 Saudi Arabia
      • 7.4.5.3.1 Saudi Arabia Parkinson's disease treatment market, 2018 - 2030 (USD Million)
      • 7.4.5.4 UAE
      • 7.4.5.4.1 UAE Parkinson's disease treatment market, 2018 - 2030 (USD Million)

Chapter 8 Parkinson's Disease Treatment Market: Company Profiles

  • 8.1 Company Profiles
    • 8.1.1 Cerevel Therapeutics
      • 8.1.1.1 Company Overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Product Benchmarking
      • 8.1.1.4 recent Developments
    • 8.1.2 Novartis AG
      • 8.1.2.1 Company Overview
      • 8.1.2.2 Financial Performance
      • 8.1.2.3 Product Benchmarking
      • 8.1.2.4 Recent Developments
    • 8.1.3 Teva Pharmaceutical Industries Ltd
      • 8.1.3.1 Company Overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Product Benchmarking
      • 8.1.3.4 Recent Developments
    • 8.1.4 Merck & Co., Inc.
      • 8.1.4.1 Company Overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Product Benchmarking
      • 8.1.4.4 Recent Developments
    • 8.1.5 GlaxoSmithKline plc. (GSK)
      • 8.1.5.1 Company Overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Product Benchmarking
      • 8.1.5.4 Recent Developments
    • 8.1.6 AbbVie, Inc.
      • 8.1.6.1 Company Overview
      • 8.1.6.2 Financial Performance
      • 8.1.6.3 Product Benchmarking
      • 8.1.6.5 Recent Developments
    • 8.1.7 H. Lundbeck A/S
      • 8.1.7.1 Company Overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Product Benchmarking
    • 8.1.8 Amneal Pharmaceuticals LLC.
      • 8.1.8.1 Company Overview
      • 8.1.8.3 Financial Benchmarking
      • 8.1.8.4 Product Benchmarking
      • 8.1.8.5 Recent Developments
    • 8.1.9 Supernus Pharmaceuticals, Inc.
      • 8.1.9.1 Company Overview
      • 8.1.9.2 Financial performance
      • 8.1.9.3 Product Benchmarking
      • 8.1.9.4 Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Parkinson's Disease Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 5 Global Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 6 North America Parkinson's Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 7 North America Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 8 North America Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9 U.S. Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 10 U.S. Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 11 Canada Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 12 Canada Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Europe Parkinson's Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 14 Europe Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 15 Europe Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Germany Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 17 Germany Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 18 U.K. Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 19 U.K. Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 France Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 21 France Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22 Italy Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 23 Italy Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 Spain Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 25 Spain Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 Asia Pacific Parkinson's Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 27 Asia Pacific Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 Japan Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 30 Japan Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 31 China Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 32 China Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 33 India Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 34 India Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 South Korea Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 36 South Korea Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 Australia Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 38 Australia Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Latin America Parkinson's Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 40 Latin America Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 41 Latin America Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Brazil Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 43 Brazil Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Mexico Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Mexico Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46 Argentina Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 47 Argentina Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 Middle East & Africa Parkinson's Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 49 Middle East & Africa Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 50 Middle East & Africa Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 Saudi Arabia Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 52 Saudi Arabia Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 South Africa Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 54 South Africa Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 UAE Parkinson's Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 56 UAE Parkinson's Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Parkinson's Disease Treatment Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation

Fig. 9 Market Outlook (2021)

  • Fig. 10 Penetration and Growth Prospect Mapping
  • Fig. 11 Parkinson's Disease Treatment Market Driver Impact
  • Fig. 12 Parkinson's Disease Treatment Market Restraint Impact
  • Fig. 13 Major Deals and Strategic Alliances
  • Fig. 14 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
  • Fig. 15 Porter's Five Forces Analysis
  • Fig. 16 Heat Map Analysis
  • Fig. 17 Company Market Share Analysis (2021)
  • Fig. 18 Company Market Position Analysis (2021), Revenue Analysis
  • Fig. 19 Company Market Position Analysis (2021), Profit Margin Analysis
  • Fig. 20 Market Differentiators
  • Fig. 21 Regional Network Map
  • Fig. 22 Parkinson's Disease Treatment Market Drug Class Outlook: Key Takeaways
  • Fig. 23 Parkinson's Disease Treatment Market: Drug Class Movement Analysis
  • Fig. 24 Carbidopa-Levodopa Market, 2018 - 2030 (USD Million)
  • Fig. 25 Dopamine Agonist Market, 2018 - 2030 (USD Million)
  • Fig. 26 MAO-B Inhibitors Market, 2018 - 2030 (USD Million)
  • Fig. 27 COMT Inhibitors Market, 2018 - 2030 (USD Million)
  • Fig. 28 Anticholinergics Market, 2018 - 2030 (USD Million)
  • Fig. 29 Others Market, 2018 - 2030 (USD Million)
  • Fig. 30 Parkinson's Disease Treatment Market Distribution Channel Outlook: Key Takeaways
  • Fig. 31 Parkinson's Disease Treatment Market: Distribution Channel Movement Analysis
  • Fig. 32 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 33 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 34 Online Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 35 Regional Outlook, 2020 & 2030
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 North America
  • Fig. 38 North America Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 39 U.S.
  • Fig. 40 U.S. Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada
  • Fig. 42 Canada Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe
  • Fig. 44 Europe Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 45 U.K.
  • Fig. 46 U.K. Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 47 Germany
  • Fig. 48 Germany Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain
  • Fig. 50 Spain Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 51 France
  • Fig. 52 France Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 53 Italy
  • Fig. 54 Italy Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific
  • Fig. 56 Asia Pacific Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 57 Japan
  • Fig. 58 Japan Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 59 China
  • Fig. 60 China Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 61 India
  • Fig. 62 India Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea
  • Fig. 64 South Korea Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 65 Australia
  • Fig. 66 Australia Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 67 Latin America
  • Fig. 68 Latin America Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil
  • Fig. 70 Brazil Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 71 Mexico
  • Fig. 72 Mexico Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 73 Argentina
  • Fig. 74 Argentina Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 75 Middle East and Africa
  • Fig. 76 MEA Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 77 South Africa
  • Fig. 78 South Africa Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia
  • Fig. 80 Saudi Arabia Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)
  • Fig. 81 UAE
  • Fig. 82 UAE Parkinson's Disease Treatment Market, 2018 - 2030 (USD Million)